Published papers
Academic conference presentation
Research areas
Education
    （Last updated : 2026-01-16 15:22:48）
  FUKUDA Hironori
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Urology
   Position   Assistant Professor
■ Published papers
1. Original article　 Impact of starting dose of tyrosine kinase inhibitors on outcomes following combination therapy of immune checkpoint inhibitors with tyrosine kinase inhibitors for previously untreated advanced renal cell carcinoma. 2026/01
2. Original article　 Outcomes of tyrosine kinase inhibitor monotherapy for advanced renal cell carcinoma arising in patients with kidney transplantation: comparison with sporadic and end‑stage renal disease populations. 2025/12
3. Original article　 Comparison of real-world outcomes between nivolumab plus ipilimumab and lenvatinib plus pembrolizumab or nivolumab plus cabozantinib combination therapies for previously untreated advanced renal cell carcinoma. 2025/10
4. Case report　 Safety of enfortumab vedotin plus pembrolizumab in hemodialysis patients with metastatic urothelial carcinoma: Case report 2025/09/01
5. Original article　 Impact of first-line dual immuno-oncology combination therapy versus immuno-oncology plus tyrosine kinase inhibitor on outcomes of second-line VEGFR-TKI in advanced RCC: a real-world multi-institutional analysis. 2025/09
Display all(85)
■ Academic conference presentation
1. Immunotherapy outcomes and immune microenvironment profiles of patients with non-clear cell renal cell carcinoma. （Poster notice，General） 2025/09/26
2. Relative changes in donor-derived cell-free DNA as a marker of allograft rejection in a kidney transplant recipient with metastatic cancer undergoing immunotherapy. （Poster notice，General） 2025/08/05
3. Comparison of clinical outcomes between cabozantinib+nivolumab and lenvatinib+pembrolizumab in advanced renal cell carcinoma. （Poster notice，General） 2025/04/28
4. Gene profile of old donor kidney related to kidney function before and after kidney transplantation. （Poster notice，General） 2025/04/28
5. Impact of cytoreductive nephrectomy on immunecheckpoint inhibitor therapy: Treatment outcomes of immune inhibitors combination therapies formetastatic renal cell carcinoma with primary kidneytumors. （Poster notice，General） 2025/04/28
Display all(56)
■ Research areas
Urology (Key Word：Urology) 
■ Education
1. 2015/04～2019/03 〔Doctoral course〕〔Doctorial Course〕 Urology, Graduate School, Division of Medical Sciences, Tokyo Women's Medical University, Completed, PhD